These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 19158197

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of 8 years of growth hormone treatment on scoliosis in children with Prader-Willi syndrome.
    Grootjen LN, Rutges JPHJ, Damen L, Donze SH, Juriaans AF, Kerkhof GF, Hokken-Koelega ACS.
    Eur J Endocrinol; 2021 May 21; 185(1):47-55. PubMed ID: 33886496
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. IGF-1 Levels, Complex Formation, and IGF Bioactivity in Growth Hormone-Treated Children With Prader-Willi Syndrome.
    Bakker NE, van Doorn J, Renes JS, Donker GH, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2015 Aug 21; 100(8):3041-9. PubMed ID: 26050733
    [Abstract] [Full Text] [Related]

  • 10. Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy.
    Festen DA, van Toorenenbergen A, Duivenvoorden HJ, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2007 Apr 21; 92(4):1549-54. PubMed ID: 17264186
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Outcomes of growth hormone treatment in children with Prader-Willi syndrome over a 30-year period: a single tertiary center experience.
    Gamage DS, Ambler G, Chan A, Srinivasan S, Maguire AM, Cho YH.
    J Pediatr Endocrinol Metab; 2024 Aug 27; 37(8):680-685. PubMed ID: 39089289
    [Abstract] [Full Text] [Related]

  • 14. Dietary Energy Intake, Body Composition and Resting Energy Expenditure in Prepubertal Children with Prader-Willi Syndrome before and during Growth Hormone Treatment: A Randomized Controlled Trial.
    Bakker NE, Siemensma EP, Koopman C, Hokken-Koelega AC.
    Horm Res Paediatr; 2015 Aug 27; 83(5):321-31. PubMed ID: 25764996
    [Abstract] [Full Text] [Related]

  • 15. Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects.
    Bakker NE, Kuppens RJ, Siemensma EP, Tummers-de Lind van Wijngaarden RF, Festen DA, Bindels-de Heus GC, Bocca G, Haring DA, Hoorweg-Nijman JJ, Houdijk EC, Jira PE, Lunshof L, Odink RJ, Oostdijk W, Rotteveel J, Schroor EJ, Van Alfen AA, Van Leeuwen M, Van Pinxteren-Nagler E, Van Wieringen H, Vreuls RC, Zwaveling-Soonawala N, de Ridder MA, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2013 Oct 27; 98(10):4013-22. PubMed ID: 24001750
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
    Craig ME, Cowell CT, Larsson P, Zipf WB, Reiter EO, Albertsson Wikland K, Ranke MB, Price DA, KIGS International Board.
    Clin Endocrinol (Oxf); 2006 Aug 27; 65(2):178-85. PubMed ID: 16886957
    [Abstract] [Full Text] [Related]

  • 17. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY, Myers S, Carrel A, Allen D.
    Pediatrics; 2002 Feb 27; 109(2):E35. PubMed ID: 11826245
    [Abstract] [Full Text] [Related]

  • 18. Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment.
    Festen DA, de Weerd AW, van den Bossche RA, Joosten K, Hoeve H, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2006 Dec 27; 91(12):4911-5. PubMed ID: 17003096
    [Abstract] [Full Text] [Related]

  • 19. Circulating insulin-like growth factor 1 levels are reduced in very young children with Prader-Willi syndrome independent of anthropometric parameters and nutritional status.
    Koizumi M, Konishi A, Etani Y, Ida S, Kawai M.
    Clin Endocrinol (Oxf); 2022 Mar 27; 96(3):346-352. PubMed ID: 34750859
    [Abstract] [Full Text] [Related]

  • 20. Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study.
    Siemensma EP, Tummers-de Lind van Wijngaarden RF, Festen DA, Troeman ZC, van Alfen-van der Velden AA, Otten BJ, Rotteveel J, Odink RJ, Bindels-de Heus GC, van Leeuwen M, Haring DA, Oostdijk W, Bocca G, Mieke Houdijk EC, van Trotsenburg AS, Hoorweg-Nijman JJ, van Wieringen H, Vreuls RC, Jira PE, Schroor EJ, van Pinxteren-Nagler E, Willem Pilon J, Lunshof LB, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2012 Jul 27; 97(7):2307-14. PubMed ID: 22508707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.